Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
Asıl Yazarlar: | , , , , , , , , , |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
KeAi Communications Co., Ltd.
2024-03-01
|
Seri Bilgileri: | Genes and Diseases |
Online Erişim: | http://www.sciencedirect.com/science/article/pii/S2352304223002039 |